K Oizumi
- Topics
- Tuberculosis Research and Epidemiology (14 papers)Mycobacterium research and diagnosis (13 papers)Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers)
- Cited by
- MicrobiologyImmunology
- Journals
- The LancetThe Journal of ImmunologyAmerican Journal of Respiratory and Critical Care Medicine
- Partner nations
- JapanUnited States
In The Last Decade
K Oizumi
55 papers receiving 675 citations
Peers
Comparison fields: 5 of 96
- Immunology 210
- Epidemiology 207
- Pulmonary and Respiratory Medicine 144
- Surgery 113
- Physiology 92
Countries citing papers authored by K Oizumi
This map shows the geographic impact of K Oizumi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Oizumi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Oizumi more than expected).
Fields of papers citing papers by K Oizumi
This network shows the impact of papers produced by K Oizumi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Oizumi. The network helps show where K Oizumi may publish in the future.
Co-authorship network of co-authors of K Oizumi
This figure shows the co-authorship network connecting the top 25 collaborators of K Oizumi. A scholar is included among the top collaborators of K Oizumi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Oizumi. K Oizumi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | Efficacy of common antiseptics against multidrug-resistant Mycobacterium tuberculosis. | 20 |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 5 | |
| 7 | 16 | |
| 8 | 94 | |
| 9 | 6 | |
| 10 | 4 | |
| 11 | 6 | |
| 12 | 66 | |
| 13 | 2 | |
| 14 | 19 | |
| 15 | 3 | |
| 16 | 9 | |
| 17 | Double blind comparative study on cefuroxime axetil vs cefaclor in bacterial respiratory tract infections. | 3 |
| 18 | [Mode of action of rifampicin on Mycobacterium tuberculosis]. | 2 |
| 19 | 5 | |
| 20 | 3 |
About K Oizumi
K Oizumi is a scholar working on Molecular Medicine, Infectious Diseases and Epidemiology, having authored 61 papers that have together received 712 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (14 papers), Mycobacterium research and diagnosis (13 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers). The work is most often cited by research in Microbiology (62 citations), Immunology (210 citations) and Microbiology (7 citations). K Oizumi has collaborated with scholars based in Japan and United States. Frequent co-authors include J Honda, K Itoh, Takafumi Yano, Toru Rikimaru, Tomoaki Hoshino, Masahiro Kondo, Yuji Honda, Yu Sato, Hiroshi Maruoka and Akiko Yamada. Their work appears in journals such as The Lancet, The Journal of Immunology and American Journal of Respiratory and Critical Care Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.